254 related articles for article (PubMed ID: 7948298)
21. [New thrombolytic agents in myocardial infarction].
Charbonnier B; Lang M; Brochier M
Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222
[TBL] [Abstract][Full Text] [Related]
22. Coronary thrombolysis with clot-selective plasminogen activators.
Collen D; Bounameaux H
Herz; 1986 Feb; 11(1):9-15. PubMed ID: 3082731
[TBL] [Abstract][Full Text] [Related]
23. [Increased efficacy of thrombolytic therapy in acute myocardial infarction by improved properties of new thrombolytic agents].
Huber K
Wien Klin Wochenschr; 2000 Sep; 112(17):742-8. PubMed ID: 11042902
[TBL] [Abstract][Full Text] [Related]
24. [Thrombolytic therapy].
Matsuda T
Nihon Rinsho; 1998 Oct; 56(10):2577-81. PubMed ID: 9796322
[TBL] [Abstract][Full Text] [Related]
25. Thrombolytic therapy.
Collen D; Lijnen HR
Ann N Y Acad Sci; 1991; 614():259-69. PubMed ID: 1902640
[No Abstract] [Full Text] [Related]
26. The ideal fibrinolytic: can drug design improve clinical results?
Van de Werf FJ
Eur Heart J; 1999 Oct; 20(20):1452-8. PubMed ID: 10493843
[No Abstract] [Full Text] [Related]
27. Reteplase set to enter thrombolytic market.
Am J Health Syst Pharm; 1997 Jan; 54(1):12. PubMed ID: 9117779
[No Abstract] [Full Text] [Related]
28. Efficacy of streptokinase, but not tissue-type plasminogen activator, in achieving 90-minute patency after thrombolysis for acute myocardial infarction decreases with time to treatment. PERM Study Group. Prospective Evaluation of Reperfusion Markers.
Steg PG; Laperche T; Golmard JL; Juliard JM; Benamer H; Himbert D; Aubry P
J Am Coll Cardiol; 1998 Mar; 31(4):776-9. PubMed ID: 9525545
[TBL] [Abstract][Full Text] [Related]
29. Frequency of "optimal anticoagulation" for acute myocardial infarction after thrombolysis with front-loaded recombinant tissue-type plasminogen activator and conjunctive therapy with recombinant hirudin (HBW 023). ALKK Study Group.
Zeymer U; von Essen R; Tebbe U; Niederer W; Mäurer W; Vogt A; Neuhaus KL
Am J Cardiol; 1995 Nov; 76(14):997-1001. PubMed ID: 7484879
[TBL] [Abstract][Full Text] [Related]
30. A randomized trial of recombinant staphylokinase versus alteplase for coronary artery patency in acute myocardial infarction. The STAR Trial Group.
Vanderschueren S; Barrios L; Kerdsinchai P; Van den Heuvel P; Hermans L; Vrolix M; De Man F; Benit E; Muyldermans L; Collen D
Circulation; 1995 Oct; 92(8):2044-9. PubMed ID: 7554180
[TBL] [Abstract][Full Text] [Related]
31. Clinical trial results with a new plasminogen activator.
Bode C; Peter K; Moser M; Smalling RW; Weaver WD
Eur Heart J; 1997 Dec; 18 Suppl F():F17-21. PubMed ID: 9447336
[TBL] [Abstract][Full Text] [Related]
32. Platelet function and fibrinolytic agents: two sides of a coin?
Callahan KP; Malinin AI; Gurbel PA; Alexander JH; Granger CB; Serebruany VL
Cardiology; 2001; 95(2):55-60. PubMed ID: 11423707
[TBL] [Abstract][Full Text] [Related]
33. [Staphylokinase for a better thrombolytic treatment of heart and platelet diseases].
Vanderschueren S
Verh K Acad Geneeskd Belg; 2000; 62(1):69-75. PubMed ID: 10769618
[TBL] [Abstract][Full Text] [Related]
34. [Tissue-type plasminogen activator and pro-urokinase--new fibrinolytic agents in the treatment of myocardial infarction].
Czyrski J
Wiad Lek; 1989 Apr; 42(7):450-2. PubMed ID: 2516932
[TBL] [Abstract][Full Text] [Related]
35. Molecular basis of fibrinolysis, as relevant for thrombolytic therapy.
Collen D; Lijnen HR
Thromb Haemost; 1995 Jul; 74(1):167-71. PubMed ID: 8578451
[TBL] [Abstract][Full Text] [Related]
36. Combinations of thrombolytic agents in acute myocardial infarction.
Bode C; Baumann H; von Hodenberg E; Freitag M; Nordt T
Z Kardiol; 1993; 82 Suppl 2():125-8. PubMed ID: 8328189
[TBL] [Abstract][Full Text] [Related]
37. Clot-selective coronary thrombolysis with pro-urokinase.
Loscalzo J; Wharton TP; Kirshenbaum JM; Levine HJ; Flaherty JT; Topol EJ; Ramaswamy K; Kosowsky BD; Salem DN; Ganz P
Circulation; 1989 Apr; 79(4):776-82. PubMed ID: 2494004
[TBL] [Abstract][Full Text] [Related]
38. New thrombolytic agents and strategies.
Collen D; Lijnen HR
Baillieres Clin Haematol; 1995 Jun; 8(2):425-35. PubMed ID: 7549072
[TBL] [Abstract][Full Text] [Related]
39. [New thrombolytic agents in myocardial infarction].
Helft G; Elalamy I; Beygui F; Dambrin G; Lecompte T; Le Pailleur C; Le Feuvre C; Metzger JP; Vacheron A; Samama MM
Arch Mal Coeur Vaiss; 1999 Apr; 92(4):411-7. PubMed ID: 10326149
[TBL] [Abstract][Full Text] [Related]
40. [Thrombolytic drugs in acute myocardial infarct].
Ambrosioni E; Degli Esposti D
Cardiologia; 1991 Dec; 36(12 Suppl 1):395-402. PubMed ID: 1841796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
